Study Stopped
difficulty with equipment
Impact of Early Mobility on Post-Surgery Recovery in Patients Undergoing Oncologic Surgeries
Does Increased Mobility Assessed With 3D Motion Tracking Technology Lead to Early Post-Operative Recovery Among Patients Undergoing Oncologic Surgeries
2 other identifiers
interventional
17
1 country
1
Brief Summary
This trial studies the impact of early mobility tracked with a 3-dimensional (3D) motion tracking technology (XSENS) on post-surgery recovery in patients undergoing oncologic surgeries. Xsens uses wireless measurements which could be used in clinical settings to objectively measure movement patterns (the joint range of movement and the distance of movement) during functional activities. Post-surgery mobility tracking may help doctors to identify the minimum required level of mobility after inpatient oncologic surgeries to enhance early post-surgery recovery and decrease early post-surgery complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 31, 2019
CompletedFirst Submitted
Initial submission to the registry
June 20, 2019
CompletedFirst Posted
Study publicly available on registry
June 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2020
CompletedResults Posted
Study results publicly available
August 31, 2021
CompletedJuly 22, 2022
July 1, 2022
11 months
June 20, 2019
June 23, 2021
July 20, 2022
Conditions
Outcome Measures
Primary Outcomes (6)
Changes in Mobility
changes in mobility (as measured by average velocity of pelvis) from baseline to discharge are compared between groups using a one-sided, two-sample t-test.
Baseline up to 30 days post discharge
Early Return of Bowel Motion
Days from operation to passing flatus and/or stool, treated as continuous measure
Up to 30 days after discharge
Presence or Absence of Nausea and/or Vomiting
Presence or absence of nausea and/or vomiting, treated as a binary variable
Up to 30 days after discharge
Presence or Absence of Chest Symptoms
Presence or absence of chest symptoms (cough, sputum, and ability of using incentive spirometry), treated as a binary variable
Up to 30 days after discharge
Early Discharge From the Hospital
Days from operation until hospital discharge, treated as continuous variable
Up to 30 days after discharge
Surgical Related Complications and Readmissions
Presence or absence of surgical complication (including readmission), treated as a binary variable
Up to 30 days after discharge
Secondary Outcomes (5)
Range of Joint Movement in Upper and Lower Joints of Body
Up to 30 days after discharge
Post-surgical Complications
Up to 30 days post discharge
Change in Exercise Habits Outside of the Hospital
Up to 3 months post discharge
Application of Sensors in a Hospital Setting
Up to 3 months post discharge
Mobility Quality of Life Questionnaire
Up to 3 months post discharge
Study Arms (2)
Arm I (usual care)
ACTIVE COMPARATORPatients walk one to two laps around the ward twice per day, and have mobility tracked with Xsens over 5-10 minutes, until discharge from hospital. Patients also mobilize (walk out of the bed) on first day post-surgery under supervision and assistant of attending nurse in the floor if the clinical situation allows.
Arm II (additional mobility)
EXPERIMENTALPatients walk for minimum 30 minutes per day and mobility is tracked with Xsens over 5-10 minutes up to discharge from hospital. Patients also mobilize (walk out of the bed) on first day post-surgery under supervision and assistant of attending nurse in the floor if the clinical situation allows.
Interventions
Receive standard of care
Eligibility Criteria
You may qualify if:
- Ambulant inpatient with a stay of \>= 2 days after any inpatient oncologic surgery
- Eastern Cooperative Oncology Group (ECOG) scale of performance status of less than 3
- American Society of Anesthesiologist score (ASA) 3 or less
- Participants who do not engage in regular exercise regimen before the surgery (other than regular occupational physical therapy)
- Participant or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
You may not qualify if:
- Patients with altered mental status
- Patients with psychiatric illness
- ECOG scale performance status 3 or more
- ASA score of 4
- Participants who engage in regular exercise regimen before surgery (at least one session per week)
- Patients with restricted movement due to other diseases
- Patients who require continuous monitoring
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Kris Attwood
- Organization
- Roswell Park Comprehensive Cancer Center
Study Officials
- PRINCIPAL INVESTIGATOR
Khurshid A Guru
Roswell Park Cancer Institute
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2019
First Posted
June 27, 2019
Study Start
May 31, 2019
Primary Completion
April 10, 2020
Study Completion
April 10, 2020
Last Updated
July 22, 2022
Results First Posted
August 31, 2021
Record last verified: 2022-07